PHASE i TRIAL OF MRI-GUIDED Prostate Cancer Lattice Extreme Ablative Dose (LEAD) BOOST Radiotherapy

A phase I clinical trial was designed to test the feasibility and toxicity of administering high-dose spatially-fractionated radiotherapy to MRI-defined prostate tumor volumes, in addition to standard treatment.

Source: International Journal of Radiation Oncology * Biology * Physics - February 17, 2020 Category: Radiology Authors: Alan Pollack, Felix M. Chinea, Elizabeth Bossart, Deukwoo Kwon, Matthew Abramowitz, Charles Lynne, Merce Jorda, Brian Marples, Vivek N. Patel, Xiaodong Wu, Isildinha Reis, Matthew T. Studenski, Javier Casillas, Radka Stoyanova Source Type: research